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Abstract
NADH and NADPH are redox coenzymes broadly required for energy metabolism, biosynthesis 
and detoxification. Despite detailed knowledge of specific enzymes and pathways that utilize these 
coenzymes, a holistic understanding of the regulation and compartmentalization of NADH and 
NADPH-dependent pathways is lacking, in part because of a lack of tools with which to 
investigate them in living cells. We previously reported the use of the naturally occurring 
Lactobacillus brevis H2O-forming NADH oxidase (LbNOX) as a genetic tool for manipulation of 
the NAD+/NADH ratio in human cells. Here we present TPNOX (triphosphopyridine nucleotide 
oxidase), a rationally designed and engineered mutant of LbNOX that is strictly specific towards 
NADPH. We characterize the effects of TPNOX expression on cellular metabolism and use it in 
combination with LbNOX to show how the redox states of mitochondrial NADPH and NADH 
pools are connected.
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Introduction
All forms of life require unremitting flux of energy, which is achieved through complex 
redox chemistry performed at the cellular level. Two pyridine dinucleotides, NADH and 
NADPH, are essential in this process due to their ability to serve as electron carriers for a 
large subset of oxidoreductases. Despite the identical redox chemistry of NAD+/NADH and 
NADP+/NADPH redox couples, and, consequently, similar standard reduction potentials 
(Eo′ = −320 mV), they work in their specific cellular environments at vastly different redox 
potentials (Eh), which are defined by the local concentrations of their oxidized and reduced 
forms. For example, in fed rat livers, the cytosolic free NAD+/NADH ratio is about 1000, 
which corresponds to a reduction potential Eh = −240 mV, while the cytosolic free NADP+/
NADPH ratio is ~0.01, which is equivalent to the reduction potential Eh ~ −400 mV1–4. 
Cells maintain NADPH mostly in the reduced form to drive reductive biosynthesis and 
reactive oxygen species (ROS) detoxification, while the NADH pool is maintained mostly in 
the oxidized state to catalyze energy-producing reactions4. The preferential utilization of 
NADPH in anabolic processes and NADH in catabolic processes is an important design 
principle of cellular metabolism that allows thermodynamically incompatible reactions to 
take place simultaneously.
The diverse metabolic functions of NADH and NADPH are possible due to the specificity 
and varied distribution of cellular enzymes that utilize these coenzymes. Though NADPH 
differs from NADH only by the presence of a single phosphate group in the 2′ position of 
the adenosine ribose, most human enzymes have evolved to selectively use either one or the 
other. Equally important is the compartmentalized distribution of these enzymes. For 
example, mammalian mitochondria, whose membrane is not permeable to pyridine 
nucleotides, maintain the NAD+/NADH pool in a more reduced state than in the cytosol. The 
difference is likely required to maintain thermodynamic favorability of oxidative 
phosphorylation in the mitochondria and glycolysis in the cytosol.
The activity of core metabolic pathways and shuttle systems help to establish the observed 
NAD+/NADH and NADP+/NADPH reduction potentials in different compartments5. The 
NAD+/NADH ratio is determined by the relative activities of glycolysis in the cytosol, the 
tricarboxylic acid (TCA) cycle and electron transport chain (ETC) in mitochondria, as well 
as the activity of shuttle systems (e.g., aspartate–malate, glycerol-3-phosphate shuttles). The 
cytosolic NADP+/NADPH reduction potential is determined primarily by the pentose 
phosphate pathway (PPP), cytosolic malic enzyme, isocitrate dehydrogenase, and one-
carbon metabolism pathway. In mitochondria, NADPH can be produced by 
transhydrogenase, malic enzyme, isocitrate dehydrogenase, and the one-carbon metabolism 
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pathway. Furthermore, several shuttle systems for conversion of mitochondrial NADPH or 
NADH into cytosolic NADPH have been proposed6,7. Knockout studies indicate redundancy 
in NADPH producing pathways5,8–10. It is not well-understood which of these pathways 
maintain the NADP+/NADPH reduction potential under different conditions.
There is growing evidence that the regulation of NAD+/NADH and NADP+/NADPH 
reduction potentials is extremely important in physiology and disease. These ratios are 
highly dynamic, changing depending on the fasting/fed state1,2, diet1,2,11, exercise12, 
circadian rhythm13, cell proliferation status14 or pathologic states including cancer14, 
diabetes1 and the aging process itself15,16. There is also growing evidence that changes in 
pool sizes of pyridine nucleotides vary with disease processes17. To what extent these 
changes are reflective of underlying pathology versus drivers of pathology is not known.
To address these questions, robust methods are needed for measuring and manipulating 
pyridine nucleotide ratios in living cells. In recent years there has been progress in the 
development of genetic reporters for detecting the dynamics of NAD+/NADH or NADP+/
NADPH in cells18–21. Mass spectrometry tracer methods for measuring fluxes through 
compartment specific NADH- and NADPH-producing pathways have also been 
developed22–25. However, methods for direct manipulation of NADH and NADPH levels in 
subcellular compartments are lacking.
We recently reported the use of NADH oxidase from Lactobacillus brevis (LbNOX)26 which 
catalyzes a four-electron reduction of oxygen to water (2NADH + 2H+ + O2 → 2NAD+ 
+ 2H2O) as a genetically encoded tool for manipulation of NAD+/NADH ratios in human 
cells. Here we report the design and validation of TPNOX, a quintuple mutant of LbNOX 
that is highly specific for NADPH. The X-ray structures of LbNOX–NADH and TPNOX–
NADPH complexes provide new insights into the substrate specificity of H2O-forming 
oxidases. We show that TPNOX is active when expressed in mammalian cells and use it in 
combination with LbNOX to demonstrate that intra-mitochondrial but not intra-cytosolic 
NADPH and NADH reduction potentials are connected.
Results
Rational design of the water-forming NADPH oxidase TPNOX
To our knowledge there are no naturally occurring H2O-forming oxidases that are highly 
specific for NADPH (2NADPH + 2H+ + O2 → 2NADP+ + 2H2O). Therefore, we sought to 
engineer an NADPH-specific mutant of the H2O-forming oxidase from L. brevis 
(LbNOX)26. Such an approach seemed feasible since several groups have had reasonable 
success in converting the NAD(P)H coenzyme specificities of various oxidoreductases27.
The NADH binding site in LbNOX and related enzymes contains two defined motifs: a 
conserved pyridine dinucleotide binding motif (DBM) GxGxxG/A, which is a part of the 
βαβ Rossmann fold domain, and an adjacent motif designated as “substrate specificity loop” 
(SSL) (Fig. 1a)27. Comparison of the amino acid sequence of LbNOX with that of 
structurally related strictly NADPH-specific enzyme glutathione reductase (GR) and other 
related enzymes helped to identify five key residues spanning both motifs (numbered 1–5 in 
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Fig. 1a). Based on the structure of LbNOX–NADH complex (determined in this study, see 
below) and the structure of GR-NADPH (PDB code 1GET) we rationalized that positions 2, 
3 and 5 contribute to the GR preference for the phosphate-bearing NADPH over NADH 
(Fig. 1b,c; Supplementary Results, Supplementary Fig. 3a and Supplementary Table 1). The 
negatively charged side chain of Asp177 (position 2) stabilizes NADH binding in LbNOX 
via two strong hydrogen bonds to the ribose hydroxyl groups in positions 2′ and 3′. To 
avoid charge repulsion with the phosphate moiety of NADPH, we replaced this residue with 
the neutral Ala, whose small side chain (rather than the larger Val197 found in GR) we 
considered less likely to interfere with the core residues of LbNOX. As the phosphate group 
of NADPH in GR interacts directly with the positively charged side chains of Arg residues 
in positions 3 and 5 (Fig. 1b,c), we substituted both Ala178 and Pro184 in LbNOX with 
arginine.
The contribution of the residue in position 4 to the substrate specificity in NOXes is 
uncertain. Dual-specificity NOXes from protozoan human parasite Giardia intestinalis and 
lactic bacterium Lactobacillus sanfranciscensis, which accept both NADH and NADPH but 
otherwise are very similar to LbNOX, have His and Ser, respectively, at this position28,29. 
Both residues are capable of hydrogen bond formation with the 2′-phosphate group of 
NADPH. GR contains Lys at this position but surprisingly it does not interact with the 
substrate (Fig. 1c). Since the active site of the proposed variant already contains two 
positively charged arginines, we substituted the hydrophobic Met179 of LbNOX with 
neutral Ser (rather than with positively charged His). It has been reported that mutations in 
the SSL that change the KM for a specific substrate in expected manner often result in a 
drastic loss of catalytic activity (kcat), an effect that can be alleviated by additional (usually 
random) mutations27. The substrate specificity of oxidases involves a still incompletely 
understood mechanism that signals the presence of the phosphate moiety at the adenosine 
end of NADPH (or the lack of it in NADH) to the distant redox site where the hydride ion 
transfer from the nicotinamide ring of NADPH to the isoalloxazine ring of FAD occurs27. In 
the case of GR, an important role in this putative mechanism appears to be played by the 
residue in the last position of the DBM motif (position 1, Fig. 1b,c) where Gly, which is 
preferred by NADH specific enzymes, is replaced with Ala30,31. Thus, we replaced Gly159 
of LbNOX with Ala. In total, we engineered a quintuple mutant of LbNOX (G159A, 
D177A, A178R, M179S, P184R; Fig. 1a, Supplementary Fig. 1), which we named 
triphosphopyridine nucleotide oxidase (TPNOX), as triphosphopyridine nucleotide is the 
classical name for NADPH.
Kinetic analysis of TPNOX activity
We purified a histidine-tagged version of TPNOX and characterized its kinetic properties 
(Fig. 2a,b, Table 1, Supplementary Fig. 2). TPNOX was extremely reactive with NADPH 
(kcat 307±68 s−1 and KM 24±3 μM) and virtually non-reactive with NADH (kcat 2.9±0.4 s−1 
and KM 264±45 μM), resulting in a final specificity for NADPH (defined as [kcat/
KM(NADPH)]/[kcat/KM(NADH)]) of 1160±391-fold (Table 1). Most importantly, TPNOX was 
as catalytically potent with NADPH as the original enzyme LbNOX with NADH. The later 
translated into the largest specificity change (defined as [final specificity(TPNOX)]/[final 
specificity(LbNOX)]) reported to date, (1.3±0.5)x108-fold (Table 1). Furthermore, 
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introduction of the five amino acid substitutions neither altered oligomerization state 
(tetramer in solution 186±3 kDa) nor changed H2O2 production (below 1% of the total 
amount of NADPH oxidized during the catalytic cycle) (Supplementary Fig. 2). The 
stoichiometry of NADPH to O2 in the TPNOX-catalyzed reaction is equal to two, which 
agrees with a H2O-forming NADPH oxidase reaction (Fig. 2b).
TPNOX enabled us to clarify some aspects of NAD(P)H specificity of NOXes, in particular 
the contributions of residues in positions 1 and 4 (Fig. 1b). Comparison of the kinetic 
parameters of TPNOX with three other LbNOX variants (mutants 1–3, Table 1) offers 
interesting insights; all three variants contain Ala in position 2 and Arg in positions 3 and 5, 
but they preserve Gly in the DBM motif. A variant that retains the original Met in position 4 
(mutant 1, Table 1) has a substantially increased KM for NADH, as compared to wild-type 
LbNOX, from 69±3 μM to 1135±329 μM, and preference for NADPH of 56±36-fold (Table 
1). Substitution of Met179 with His (mutant 2) or Ser (mutant 3), the residues capable of 
hydrogen bond formation with the phosphate moiety of NADPH, causes a substantial 
decrease in KM for NADPH, which is paralleled by a decrease in kcat, leading to only a 
moderate (~9-fold) increase in catalytic efficiency. It appears that the hydrogen bond 
between the side chain of Ser179 (mutant 3) or His179 (mutant 2) and the phosphate group 
stabilizes the binding of both the substrate and the oxidized product, which leads to a 
decrease in kcat if product dissociation is rate-limiting. Interestingly, changes in the catalytic 
activity of mutants 1–3 with respect to NADH follow a similar trend (Table 1), which 
suggests a possibility of a direct hydrogen bond interaction between the side chains of 
His179 or Ser179 and the ribose 2′ hydroxyl. These observations explain why there is little 
improvement in specificity despite a notable decrease in KM among the three mutants we 
tested.
All variants where residues were mutated in positions 2–5 were active with NADPH but still 
accepted NADH as a substrate with a catalytic efficiency too high to be useful in cellular 
studies. The presence of Ala in place of Gly in the last position of the GxGxxG/A motif led 
to the highest kcat with NADPH (307±68 s−1) and lowest kcat with NADH (2.9±0.4 s−1), 
which together with respective changes in KM, yield unprecedented increase in both final 
specificity and specificity change compared to the wild-type protein (Table 1).
Structural basis for the substrate specificity in TPNOX
The determinants of NAD(P)H recognition in the SSL (Fig. 1b,c), which directly affect the 
KM for a coenzyme are relatively straightforward: binding is governed by the interaction 
preferences of the phosphate group in the 2′ position of the ribose ring32. In contrast, the 
mechanism of communication between this site and the catalytic site which impacts kcat is 
far from clear27. To shed light on that mechanism, we determined the crystal structures of 
LbNOX and TPNOX complexed with NADH and NADPH, respectively, and compared them 
to the structure of LbNOX (PDB code 5ER0) (Fig. 3, Supplementary Tables 1–2, 
Supplementary Figs. 3–4). In substrate-free LbNOX, the access to the isoalloxazine ring of 
FAD is blocked by the phenol rings of two Tyr residues (Tyr157 and Tyr186) (Fig. 3a). Only 
on their displacement (due to a transition to a different rotamer) can the nicotinamide ring of 
NADH come into proximity of FAD as required for hydride ion transfer (Fig. 3b). This 
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“two-tyrosine” switch of LbNOX is distinct from the one previously described for GR33,34, 
which involves only one Tyr residue structurally equivalent to Tyr157 of LbNOX. The 
second tyrosine (Tyr186) of LbNOX either supports Tyr157 in its blocking position in 
coenzyme-free LbNOX structure or contributes to substrate binding via a hydrogen bond 
with the diphosphate moiety in the LbNOX–NADH complex.
Comparison of the TPNOX–NADPH and LbNOX–NADH complexes reveals subtle 
differences in the position and orientation of the adenosine ribose and of the diphosphate 
moieties (Fig. 3c,d). The ribose ring of NADPH is slightly rotated compared to that of 
NADH due to the absence of Asp177 in TPNOX, which in the LbNOX–NADH structure 
forms strong hydrogen bonds with the ribose hydroxyls in 2′ and 3′ positions. The absence 
of Asp177 also allows rotation of Gly154, the first residue in the GxGYxG/A nucleotide 
binding motif, causing its carbonyl group to move away from the Ala159 side chain. The 
adenosine moiety of bound NADPH is positioned higher above the GxGYxA loop of the 
Rossman fold compared to NADH in the LbNOX–NADH complex (Fig. 3c,d). The position 
of Tyr157, on the opposite side of the helix with respect to Ala159, is influenced by Gly154–
Ala159 contact. Thus, we propose that the path of communication between the 2′ phosphate 
moiety of NADPH and the redox site involves the Gly154–Ala159 contact, which might 
facilitate displacement of Tyr157 side chain from its blocking position. The G159A 
mutation, specifically the Cβ atom of Ala159, appears to compensate for the rotation of 
Gly154 and the higher position of the ribose ring, which explains the critical role of this 
substitution in retaining the enzymatic activity of TPNOX compared to LbNOX. The 
TPNOX–NADPH structure provides an explanation for the large decrease in KM upon 
introduction of Ser in position 4. This residue makes a strong hydrogen bond to the 
phosphate oxygen atoms of NADPH. Unexpectedly, we found substantial differences in the 
conformation of the substrate binding loop among the four independently refined TPNOX 
monomers (Supplementary Fig. 4) suggesting flexibility of interaction with the substrate. 
However, due to fortuitous crystal lattice packing, in which the substrate binding loops of 
adjacent monomers abut each other, the interacting residues might be restricted in mobility 
and their ability to interact with the substrate in the crystal.
Together, the structural and enzyme kinetics data highlight the importance of the interplay 
between the SSL and the DBM. The D177A and G159A mutations change the backbone 
conformation of DBM, while the M179S mutation provide a hydrogen bond for the 
phosphate moiety of NADPH, an interaction further facilitated by the positive charge of 
Arg178 and possibly Arg184.
Expression and activity of TPNOX in human cells
We used lentiviral infection to generate HeLa cells expressing untargeted or mitochondria-
targeted TPNOX (mitoTPNOX) under the control of doxycycline inducible promoter 
TRE3G. To compare the effects of TPNOX and LbNOX side-by-side, we also generated 
HeLa cells that express LbNOX and mitoLbNOX. TPNOX, mitoTPNOX, LbNOX and 
mitoLbNOX were expressed at similar levels when induced with doxycycline (Fig. 4a). 
Expression of TPNOX or mitoTPNOX was well-tolerated, as cells appeared grossly normal 
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in morphology, and exhibited normal proliferative rates (see below). Cell fractionation 
demonstrated that the expressed proteins are properly localized in HeLa cells (Fig. 4b).
To determine whether the TPNOX expressed in human cells is enzymatically active, we took 
advantage of the fact that TPNOX consumes oxygen. Expression of TPNOX, mitoTPNOX, 
LbNOX or mitoLbNOX increased oxygen consumption by 1.7, 2.6, 1.9 or 4.2-fold, 
respectively (Fig. 4c). The increase in oxygen consumption was resistant to antimycin, an 
inhibitor of complex III of the ETC, indicating that it is due to oxidase activity of TPNOX 
and not due to increase in ETC activity. Higher activity of mitoTPNOX compared to 
TPNOX is likely due to higher concentration of NADPH in mitochondria compared to 
cytosol, which is supported by fractionation experiments35. We note that it is important to 
take into account that in addition to oxidizing NADPH to NADP+, TPNOX also consumes 
protons and oxygen and, therefore, could affect cellular pH or oxygen levels, depending on 
experimental context.
We also evaluated the effect of TPNOX and mitoTPNOX expression on whole cell NADP+ 
and NADPH levels. Expression of mitoTPNOX led to a 1.5-fold increase in the whole-cell 
NADP+/NADPH ratio, while expression of TPNOX did not have a significant effect (Fig. 
4d). The effect of mitoTPNOX on the NADP+/NADPH ratio is likely to be driven by 
changes in mitochondrial NADP+ amounts because the whole-cell NADPH amount is in 
large excess compared to the whole-cell NADP+ amount (Supplementary Fig. 6) and the 
majority of cellular NADP+ resides within mitochondria35.
Effects of TPNOX and LbNOX on intermediary metabolism
We used GC-MS and flux measurements to characterize the effect of TPNOX, mitoTPNOX, 
LbNOX and mitoLbNOX on cellular metabolism. First, we determined the effect of 
TPNOX, mitoTPNOX, LbNOX and mitoLbNOX expression on intracellular metabolite 
levels using GC-MS (Supplementary Data Set 1). Out of 97 quantified metabolites, 24 
changed significantly (p < 0.05, ANOVA followed by Tukey’s posttest), including fourteen 
TCA cycle and PPP intermediates or related metabolites. TPNOX expression led to an 
increase in PPP intermediates while mitoTPNOX, LbNOX or mitoLbNOX expression led to 
an increase in TCA cycle intermediates (Fig. 5a). To confirm that these metabolite changes 
lead to changes in corresponding pathway fluxes, we used 14CO2 production from 1-14C-
glucose (produces 14CO2 through the action of 6-phosphogluconate dehydrogenase (PGD)) 
and 1-14C-glutamine (produces 14CO2 through the action of alpha-ketoglutarate 
dehydrogenase (OGDH)) to measure PPP and TCA cycle fluxes, respectively. In agreement 
with GC-MS data, TPNOX increased PPP flux while mitoTPNOX, LbNOX and 
mitoLbNOX increased TCA cycle flux (Fig. 5b,c). We observed no significant change in 
glucose consumption or lactate production, except for a small decrease of lactate secretion 
caused by LbNOX (Fig. 5d,e). The latter effect is likely due to the increase of cytosolic 
NAD+/NADH ratio caused by LbNOX, which should lead to higher secretion of glycolytic 
pyruvate at the expense of lactate without affecting glucose uptake rate.
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Mitochondrial NADH and NADPH pools are connected
Our observation that mitoTPNOX but not TPNOX led to activation of the TCA cycle 
prompted us to investigate the connection between compartment-specific NAD+/NADH and 
NADP+/NADPH reduction potentials. We observed that mitoTPNOX, LbNOX or 
mitoLbNOX, but not TPNOX, increased the whole-cell NAD+/NADH ratio (Fig. 5f, 
Supplementary Fig. 6). We interpret the changes in the whole-cell NAD+/NADH ratio as 
reflective of changes in the mitochondrial NAD+/NADH ratio because the changes are 
mostly due to NADH levels and most of the NADH inside the cell is localized to 
mitochondria3,35,36. In agreement with these results, mitoTPNOX, LbNOX or mitoLbNOX, 
but not TPNOX, increased the levels of TCA cycle intermediates and flux through OGDH, a 
TCA cycle enzyme regulated by mitochondrial NAD+/NADH (Fig. 5a,c). Our observation 
that mitoTPNOX expression can impact mitochondrial NAD+/NADH ratio and TCA cycle 
flux shows that intra-mitochondrial NAD+/NADH and NADP+/NADPH reduction potentials 
are connected. It is noteworthy that mitoLbNOX expression did not cause an increase of the 
whole-cell NADP+/NADPH ratio, indicating that mitochondrial NAD+/NADH and NADP+/
NADPH reduction potentials are connected asymmetrically. That is, oxidation of NADP+/
NADPH leads to oxidation of NAD+/NADH but not vice versa. The observation that 
LbNOX but not TPNOX can increase the levels of pyruvate, TCA cycle intermediates, TCA 
cycle flux and NAD+/NADH ratio (Fig. 5a,c,f) shows that cytosolic NAD+/NADH and 
NADP+/NADPH reduction potentials are not connected. This is further supported by the fact 
that TPNOX but not LbNOX can increase the levels of PPP intermediates and PPP flux, 
which is allosterically regulated by the effect of NADP+/NADPH ratio on the rate-limiting 
PPP enzyme glucose-6-phosphate dehydrogenase.
mitoTPNOX, but not TPNOX, complements an impaired ETC
Mammalian cells with a dysfunctional ETC cannot proliferate in the absence of uridine and 
pyruvate in cell culture media37,38. We previously used LbNOX to formally demonstrate that 
pyruvate is required to stimulate NAD+ regeneration and that expression of LbNOX or 
mitoLbNOX can substitute for the pyruvate requirement26. Here, we tested whether TPNOX 
or mitoTPNOX can also rescue cell proliferation in the presence of Complex I inhibitor 
piericidin. Expression of mitoTPNOX but not TPNOX rescued pyruvate auxotrophy (Fig. 
5g), thus supporting the conclusion that NAD+/NADH and NADP+/NADPH reduction 
potentials are connected in mitochondria but not in the cytosol. These results also suggest 
that under our experimental conditions in HeLa cells there is no shuttle system that would 
allow for rapid exchange between cytosolic NADPH and mitochondrial NADH, as has been 
described for some tissues6.
Discussion
We have described the design and validation of TPNOX, a genetically encoded tool for 
compartment-specific manipulation of the NADP+/NADPH ratio in living cells. We believe 
that this tool will complement LbNOX by enabling the scientific community to study the 
regulation and physiological role of compartment-specific NADP+/NADPH reduction 
potential changes in living cells.
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Understanding NAD(P)H coenzyme specificity in oxidoreductases is an important and still 
not fully resolved problem in enzymology27. A major challenge in engineering NAD(P)H 
coenzyme specificity is that the phosphate group in the 2′ position of adenosine, which 
distinguishes NADPH from NADH, affects the kinetics of the enzyme despite the fact that it 
is distant from the chemically active nicotinamide ring, where the hydride ion transfer to the 
isoalloxazine moiety of FAD occurs. Despite multiple published examples of switching 
specificity outside of the two-dinucleotide-binding flavoprotein group of oxidoreductases, 
the full reversal of substrate specificity for an enzyme which is strictly specific for one 
coenzyme has not been reported27. In GR from E. coli, the NADPH-to-NADH switch 
resulted in modest final specificity (8.1-fold) and specificity change (1.8x104-fold)30,39. In a 
recent study, a H2O-forming oxidase from Streptococcus mutans was used to create a panel 
of mutants with varying substrate specificity 40. Although one of these variants had the same 
amino acids in positions 2, 3 and 5 as TPNOX, its final specificity for NADPH was only 10-
fold40. To the best of our knowledge the only published examples of engineered enzymes 
with final specificity similar to that of LbNOX and TPNOX are the amphibian Rana perezi 
alcohol dehydrogenase (ADH8) with 7600-fold NADP+-to-NAD+ switch and Thermus 
thermophilus isopropylmalate dehydrogenase (IMDH) with 1000-fold NAD+-to-NADP+ 
switch41,42. However, in both cases the wild-type enzyme is not strictly specific for one 
coenzyme. TPNOX from this study is as catalytically active with NADPH [(1.2±0.3)x107 
s−1 M−1] as the wild-type LbNOX with NADH [(9.3±0.5)x106 s−1 M−1] with final 
specificity of 1160±391-fold and specificity change of (1.3±0.5)x108-fold (Table 1). The 
highest NADP+-to-NAD+ specificity change reported previously was that of isocitrate 
dehydrogenase from E. coli (1.4x106-fold) and for NAD+-to-NADP+ change, that of IMDH 
from T. thermophilus (8.7x104-fold)42,43.
Previously reported structures of NOXes, including LbNOX, lacking NADH or NADPH 
coenzymes limited our ability to pinpoint the mechanism of substrate specificity in this 
group of enzymes26,29,44. Our results with LbNOX and TPNOX bound to their respective 
substrates are generally consistent with previous findings on related enzymes, and 
substantially expand our understanding of the substrate specificity in NOXes (Fig. 3, 
Supplementary Figs. 3–4, Supplementary Tables 1–2). We confirmed the role of Tyr157 of 
LbNOX; the structurally equivalent residues in GR from E. coli (Tyr197) or human (Tyr177) 
are biochemically and structurally well-characterized33,34,45,46. Upon NADPH binding this 
tyrosine swings out allowing access of nicotinamide moiety of NADPH to the isoalloxazine 
ring of FAD, in similar fashion to that of Tyr157 in LbNOX–NADH or TPNOX–NADPH 
(Fig. 1a, Fig. 3a,b). The initial role of this tyrosine in GR as a simple “lid” on the NADPH-
binding pocket and protection of reduced flavin during the catalytic cycle was subsequently 
dismissed33,34. It is clear, however, that Tyr157 and the nicotinamide ring mutually exclude 
each other from contacting FAD. We also observed a change in the position of Tyr186, 
which is a part of the SSL and which is not conserved in GR or other NOXes (Figs. 1a and 
3a,b). Tyr186 supports Tyr157 in the blocking position in the absence of substrate and 
contributes to substrate binding by forming a hydrogen bond with the diphosphate moiety of 
NAD(P)H. Comparison of the LbNOX–NADH and TPNOX–NADPH structures suggests a 
role for the Gly/Ala substitution in the last position of GxGYxG/A nucleotide binding motif 
in the remarkable NADH-to-NADPH change in specificity. Apparently, the contact between 
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Gly154 and G/A159 is of importance. In TPNOX, the G159A substitution compensates for 
the change in the position of the ribose ring of NADPH and restores the communication 
between the coenzyme binding site and Tyr157, which is important for catalysis (Fig. 3c,d).
Compartmentalization of redox reactions is one of the most important design principles of 
metabolism and can be achieved chemically (through the use of specific coenzymes), 
temporally (by performing reactions at distinct times), or physically (through deploying 
enzymes in specific subcellular compartments). Using LbNOX, we previously showed in 
HeLa cells that oxidation of NADH within mitochondria leads to a secondary oxidation of 
cytosolic NADH, likely via shuttle systems26. Here, we used LbNOX in combination with 
TPNOX to understand how cytosolic and mitochondrial NAD+/NADH and NADP+/NADPH 
pools are connected in HeLa cells. We provide evidence in living HeLa cells that 
mitochondrial NAD+/NADH and NADP+/NADPH pools are connected. Specifically, we 
found that expression of mitoTPNOX, like mitoLbNOX, can increase the whole-cell NAD+/
NADH ratio, can increase TCA cycle flux and levels of TCA cycle intermediates, and can 
rescue the proliferative defect in cells with inhibited ETC (Fig. 5a–g). It is known that 
mitochondria contain three classes of enzymes that in principle can mediate exchange of 
reducing equivalents between NADH and NADPH (Fig. 5h). First, transhydrogenase is a 
mitochondrial inner membrane enzyme that catalyzes transfer of hydride ion from NADH to 
NADP+ while dissipating the proton motive force. Second, mitochondrial glutamate 
dehydrogenase can actually use either NADH or NADPH. Third, mitochondria contain 
several paralogous enzymes that use NADH or NADPH with high specificity to perform the 
same reaction. Metabolic tracing experiments that detect preferential deuterium label 
transfer from cytosolic NADH to mitochondrial NADPH over cytosolic NADPH are 
consistent with our results if we take into account the fact that malate–aspartate shuttle 
should transfer a deuterium label between cytosolic and mitochondrial NADH pools24.
Our data indicate that cytosolic reducing equivalents do not rapidly exchange between 
NAD+/NADH and NADP+/NADPH. To the best of our knowledge, the cytosol does not 
contain enzymes that can use either NAD+/NADH or NADP+/NADPH to catalyze the same 
reaction. However, it has been proposed that cytosolic NAD+- and NADP+-dependent 
dehydrogenases are connected through one of the substrates and operate close to equilibrium 
(e.g. lactate dehydrogenase and malic enzyme)47. While LbNOX rescues the proliferative 
defect in cells with an interrupted ETC, cytosolic TPNOX cannot (Fig. 5g). Moreover, 
TPNOX expression increases PPP flux and levels of PPP intermediates but does not impact 
the whole-cell NAD+/NADH ratio or TCA cycle flux, suggesting that cytosolic NAD+/
NADH and NADP+/NADPH reduction potentials are not connected. Our results are 
supported by metabolic tracing experiments that report no exchange of deuterium label 
between cytosolic NADPH and whole-cell NADH and preferential deuterium label transfer 
from cytosolic NADH to mitochondrial NADPH over cytosolic NADPH24.
In HeLa cells, mitochondrial pyridine nucleotide pools are connected asymmetrically, where 
oxidation of mitochondrial NADPH causes oxidation of mitochondrial NADH but not vice 
versa. This conclusion is supported by similar observations achieved using indirect 
methods48. The mechanism of this asymmetry is currently unknown but could be the result 
of the activity of transhydrogenase in the mitochondria. Such asymmetry may be beneficial 
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to the cell since mitochondrial NAD+/NADH ratios fluctuate depending on ATP demand and 
respiratory fuel availability, while NADP+/NADPH reduction potential may need to remain 
stable to ensure adequate biosynthetic capacity and guard against oxidative stress.
Online Methods
Cell lines
HeLa cells were purchased from ATCC (CCL-2) and were cultured in DMEM without 
pyruvate (US Biological, D9802) supplemented with 3.7 g/l NaHCO3, 10% dialyzed FBS 
(Life Technologies, 26400-044). Lentiviral-infected HeLa cells were cultured in DMEM 
without pyruvate (US Biological, D9802) supplemented with 3.7 g/l NaHCO3, 10% dialyzed 
FBS (Life Technologies, 26400-044), 500 μg/ml geneticin (Life Technologies, 10131-035) 
and 10 μg/ml puromycin (Life Technologies, A1113803). All of the experiments were 
performed in the absence of geneticin and puromycin. Cells were regularly tested for 
mycoplasma and were mycoplasma free.
Plasmids and construction of different mutants
A synthetic TPNOX gene cloned into pUC57 vector was obtained from Genewiz (See 
Supplementary Fig. 1). TPNOX-encoding gene was digested with BamHI and XhoI and 
subcloned into a pET30a vector (Novagen). LbNOX variants D177A/A178R/P184R, 
D177A/A178R/M179H/P184R and D177A/A178R/M179S/P184R were obtained using a 
Quickchange Lightning site-directed mutagenesis Kit (Agilent) using pET30a plasmid 
containing TPNOX sequence as a template and the following primers (only sense sequences 
are shown):
A159G: 5′-GGCGCCGGATACATCGGAGCCGAACTGGCCGAGGCC-3′
S179H: 5′-CTTCCTCATGACCCTAGCATGTCTGGCAATCAGGGT-3′
S179M: 5′-CGTCACCCTGATTGCCAGAATGGCTAGGGTCATGAG-3′
For expression in mammalian cells synthetic TPNOX and mitoTPNOX genes cloned into 
pUC57 vector were obtained from Genewiz (See Supplementary Fig. 1) and were 
subsequently subcloned into a pLVX-TRE3G vector (Clontech) using NotI and XhoI 
restriction cites.
Enzyme expression and purification
Recombinant TPNOX and other LbNOX variants were expressed in One Shot BL21(DE3) 
competent E. coli cells (Thermo Fisher Scientific) and purified as described previously26. 
Proteins were immediately frozen in liquid nitrogen and stored at −80 °C until use. For all 
activity assays enzymes were cleaved with Enterokinase (EMD Millipore) to remove the N-
terminal Hisx6 tag as described previously26. In crystallization experiments non-cleaved 
proteins were used.
Enzyme activity assays
Activity of enzymes with NAD(P)H (0.5–600 μM) was measured at 37°C by monitoring the 
decrease in absorbance at 340 nm in 50 mM NaPi, pH 7.5 buffer with 150 mM NaCl at 37°C 
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as described previously26. Each individual rate measurement was performed in duplicate or 
triplicate. Kinetic parameters reported are based on three individual experiments. The values 
of the kinetic parameters (KM and Vmax) were determined from fitting data with the 
Michaelis–Menten equation with SigmaPlot 13.0. Final specificity was calculated as [kcat/
KM(NADPH)]/[kcat/KM(NADH)] and specificity change was calculated as [final specificity of 
LbNOX variants]/[final specificity of wild-type LbNOX]27. To determine simultaneous 
oxygen and NADPH consumption a custom-built fluorimeter was used as described 
previously26. H2O2 production was monitored in a continuous assay based on the 
AmplexRed kit (Abcam) as described previously26 (See Supplementary Fig. 2).
Crystallization and soaking experiments with NADH and NADPH
Initial screen to identify crystallization conditions for TPNOX was performed using a 
NanoTransfer NT8 pipetting robot and a Rock Maker for storage and imaging of trays 
(Formulatrix, MA). TPNOX (10 mg/ml in 10 mM HEPES, pH 7.5 buffer with 100 mM 
NaCl) was mixed with the mother liquor solutions (0.1 μl of protein solution and 0.1 μl of 
precipitant solution) from the MCSG Suite (Microlytic, MA) and incubated over a 50 μl 
reservoir in the sitting drop plates. Hanging drops (2 μl) were set up and equilibrated against 
200 μl of reservoir solution to generate crystals for substrate soaking experiments for 
LbNOX and TPNOX. Crystals were grown in 20 % PEG 3350, 0.2 M NH4Cl for LbNOX 
and in 25 % PEG 3350, 0.1 M Bis-Tris, pH 6.5, 0.2 M (NH4)2SO4 for TPNOX at 21 °C. 
Crystals were briefly soaked for 1–3 min in the formulation with 15 % (v/v) of ethylene 
glycol supplemented with 20–30 mM NADH or NADPH and were quickly frozen in liquid 
nitrogen.
X-ray diffraction data, structure determination and refinement
X-ray diffraction data were collected at beamline 8.2.2 at the Advanced Light Source 
(Berkeley, CA). Data collected at λ=0.97 or 1.00 Å were indexed, integrated, and scaled 
using the software HKL-2000. PHENIX package was used to determine structures with 
molecular replacement using LbNOX structure (PDB code 5ER0) as a model. Ligands were 
added at later stages of the refinement using Phenix.refine to eliminate bias and structure 
was edited with COOT. Refinement of the TPNOX-NADPH structure required correction for 
twinning (estimated twinned fraction ~37%). All figures depicting X-ray structures were 
generated using PyMol. Data collection and refinement statistics for both LbNOX-NADH 
and TPNOX-NADPH are reported in Supplementary Tables 1–2. Ramachandran plot 
statistics for the LbNOX-NADH structure, is as follows: favoured (96.84 %), allowed 
(3.16 %), outliers (0.00 %) and rotamer outliers (2.40 %). Statistics for the TPNOX-NADPH 
structure, is as follows: favoured (92.74 %), allowed (7.04 %), outliers (0.23 %) and rotamer 
outliers (4.95 %).
Lentivirus production
Half a million HEK293T cells were seeded per well in a 6-well plate (one plate per 
lentivirus) in 2 ml of High glucose DMEM (Life Technologies, 11995) with 10% FBS 
(Sigma, F2442). The next evening the medium was replaced with fresh DMEM and cells 
were transfected with 100 μl of transfection mixture per well. The transfection mixture 
contained 3 μl X-treme Gene 9 reagent (Roche, 06365787001), 500 ng psPAX2 (psPAX2 
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was a gift from Didier Trono, Addgene plasmid # 12260), 50 ng pMD2.G (pMD2.G was a 
gift from Didier Trono, Addgene plasmid # 12259), 500 ng of pLVX-Tet3G (Clontech) or 
pLVX-TRE3G-Luciferase (Clontech) or pLVX-TRE3G-LbNOX or pLVX-TRE3G-
mitoLbNOX or pLVX-TRE3G-TPNOX or pLVX-TRE3G-mitoTPNOX and Opti-MEM 
medium (Life Technologies, 31985-070) up to 100 μl. To make the transfection mixture, 50 
μl solutions of X-treme Gene 9 and DNA mixtures were prepared separately and the DNA 
solution was added dropwise to the X-treme Gene 9 solution. The mixture was incubated at 
room temperature for 30 min before adding it to cells. Two days after transfection, medium 
was collected, centrifuged at 500 x g for 5 min to pellet cells and the supernatant was 
aliquoted and stored at −80 °C.
Generation of HeLa Tet3G Luciferase, LbNOX, mitoLbNOX, TPNOX and mitoTPNOX cell 
lines
Hela Tet3G cells were produced first using lentivirus from pLVX-Tet3G (Clontech) vector 
and then HeLa Tet3G cells were infected with corresponding lentivirus from pLVX-TRE3G-
Luciferase, LbNOX, mitoLbNOX, TPNOX or mitoTPNOX to generate corresponding cell 
lines. Twenty thousand HeLa cells were seeded in 2 ml of DMEM without pyruvate (US 
Biological, D9802) supplemented with 3.7 g/l NaHCO3, and 10% dialyzed FBS (Life 
Technologies, 26400-044) per well in a 6-well plate. Twenty-four hours after seeding, 2 ml 
of lentivirus solution (0.6 ml for Tet3G lentivirus) was added per well. Twenty-four hours 
after infection medium was replaced. After an additional twenty-four hours, medium was 
replaced with 2 ml of DMEM without pyruvate (US Biological, D9802) supplemented with 
3.7 g/l NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044), 500 μg/ml geneticin 
(Life Technologies, 10131-035) and 1 μg/ml puromycin (Life Technologies, A1113803). 
Cells were selected for one week, frozen and stored in liquid nitrogen. Cells were cultured in 
the presence of 500 μg/ml geneticin and 10 μg/ml puromycin and all the experiments were 
performed within a month after thawing fresh aliquot of cells.
Determination of cellular localization of expressed proteins
Localization of overexpressed LbNOX, mitoLbNOX, TPNOX and mitoTPNOX was 
determined using cell fractionation experiments as previously described26. Protein levels 
were detected using western blot with antibodies for FLAG tag (Cell Signaling, cat. No. 
2368, dilution 1:1000), LRPPRC (Sigma, cat. No. SAB2700419-100UL, dilution 1:1000), β-
actin (Cell Signaling, cat. No. 8457S, dilution 1:1000) and ATP5A (Abcam, cat. No. 
ab14748, dilution 1:1000).
Oxygen consumption
Cells were seeded at 30–40 x 103 per well in XF24 24-well cell culture microplates in 200 μl 
of DMEM without pyruvate (US Biological, D9802) supplemented with 3.7 g/l NaHCO3 
and 10% dialyzed FBS (Life Technologies, 26400-044) and were incubated at 37 °C in 5% 
CO2 incubator. Twenty-four hours later, 800 μl of media was added per well supplemented 
with doxycycline (final concentration – 300 ng/ml) or water. Twenty-four hours later, media 
was replaced with 950 μl of DMEM without pyruvate (US Biological, D9802) supplemented 
with 25 mM HEPES-KOH, pH 7.4 and 10% dialyzed FBS (Life Technologies, 26400-044) 
and OCR was measured using Seahorse XF24-3. Each measurement was performed over 4 
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min after a 2-min mix and a 2-min wait period. Basal measurements were collected 7 times 
and 2 measurements were collected after injection of antimycin (final concentration 1 μM). 
Measurements before and after addition of antimycin were averaged and normalized by the 
cell number.
GC-MS analysis of metabolites
Four million HeLa Tet3G Luciferase, LbNOX, mitoLbNOX, TPNOX or mitoTPNOX cells 
were seeded per 15 cm dish in 25 ml of DMEM without pyruvate (US Biological, D9802) 
supplemented with 3.7 g/l NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044). 
Twenty four hours later, media was exchanged to 25 ml of DMEM without pyruvate (US 
Biological, D9802) supplemented with 3.7 g/l NaHCO3, 10% dialyzed FBS (Life 
Technologies, 26400-044) and 300 ng/ml doxycycline. Twenty four hours later, media was 
again exchanged to DMEM without pyruvate (US Biological, D9802) supplemented with 
3.7 g/l NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044) and 300 ng/ml 
doxycycline. Two hours later, media was aspirated, cell culture dish was placed on an ice-
cold metal plate, cells were rinsed with 25 ml of ice-cold 0.9% NaCl for no more than 10 
seconds, 5 ml of dry-ice cold 80% methanol was added, the plate was transferred to dry ice 
metal plate, cells were scraped with cell lifter for 30 sec and the lysate was transferred to 15 
ml conical tube on dry ice. Thirty minutes later, cells were centrifuged at 1342 x g at 4 °C 
for 10 min. Supernatant was collected and stored on dry ice. The pellet was resuspended in 1 
ml of 80% methanol on wet ice, vortexed for 10 sec, incubated for 15 min on wet ice and 
spun at 2000 x g for 5 min. The pellet was re-extracted one more time and all the 
supernatants were combined and stored at −80 °C overnight. Supernatants were evaporated 
using a Speedvac (without heating) and shipped to the Metabolomics Core Facility at the 
University of Utah on dry ice. Metabolomics analysis was performed at the Metabolomics 
Core Facility at the University of Utah which is supported by 1 S10 OD016232-01, 1 S10 
OD021505-01 and 1 U54 DK110858-01. All GC-MS analysis was performed with an 
Agilent 7200 GC/Q-TOF fit with a CTC autosampler. Dried samples were suspended in 40 
μL of 40 mg/mL O-methoxylamine hydrochloride (MOX) in pyridine and incubated for one 
hour at 30°C. Twenty five μL of this solution was added to autosampler vials and 40 μL of 
N-methyl-N-trimethylsilyltrifluoracetamide (MSTFA) was added automatically via the 
autosampler and incubated for 60 minutes at 37°C with shaking. After incubation 3 μL of a 
fatty acid methyl ester standard (FAMES) solution was added followed by a 1 μL injection 
into the gas chromatograph. The split mode with the inlet temperature was held at 250°C. A 
10:1 split ratio was used for analysis. The gas chromatograph had an initial temperature of 
95°C for one minute followed by a 40°C/min ramp to 110°C and a hold time of 2 minutes. 
This was followed by a second 5°C/min ramp to 250°C, a third ramp to 350°C, then a final 
hold time of 3 minutes. A 30-meter Phenomex ZB-5 MSi column with a 5-meter guard 
column was employed for chromatographic separation. Helium was used as the carrier gas at 
a rate of 1 mL/min. Due to the high amounts of several metabolites, the samples were 
analyzed once more at a tenfold dilution.
Determination of total NAD+/NADH and NADP+/NADPH ratios
Four hundred thousand HeLa Tet3G Luciferase, LbNOX, mitoLbNOX, TPNOX or 
mitoTPNOX cells were seeded per 6 cm dish in 3 ml of DMEM without pyruvate (US 
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Biological, D9802) supplemented with 3.7 g/l NaHCO3, 10% dialyzed FBS (Life 
Technologies, 26400-044). Twenty four hours later, media was exchanged to 3 ml of DMEM 
without pyruvate (US Biological, D9802) supplemented with 3.7 g/l NaHCO3, 10% dialyzed 
FBS (Life Technologies, 26400-044) and 300 ng/ml doxycycline. Twenty four hours later, 
media was again exchanged to DMEM without pyruvate (US Biological, D9802) 
supplemented with 3.7 g/l NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044) and 
300 ng/ml doxycycline. Two hours later, media was aspirated, cell culture dish was placed 
on an ice-cold metal plate, cells were rinsed with 3 ml of ice-cold PBS for no more than 10 
seconds, 0.5 ml of ice-cold 1:1 mixture of PBS and 1 % DTAB in 0.2 M NaOH was added, 
cells were scraped for 20 seconds and transferred to an ice-cold 1.5 ml centrifuge tube. Cell 
lysate was immediately divided into two 200 μl aliquots. One aliquot was left as is and the 
other aliquot was supplemented first with 2 μl of 1 M ascorbic acid and then with 100 μl of 
0.4 M HCl with 10 mM ascorbic acid. Addition of ascorbic acid is essential for preventing 
chemical oxidation of NAD(P)H into NAD(P)+ under low pH conditions, which can lead to 
overestimation of intracellular NADP+ levels by several fold49. Both aliquots were heated at 
60°C for 20 min to destroy reduced or oxidized nucleotides and NAD+, NADH, NADP+ and 
NADPH levels were determined using Promega NAD+/NADH-Glo or NADP+/NADPH-Glo 
kits using manufacturer’s instructions (Catalog numbers, G9071 and G9081). Assay was 
validated by recovering known amounts of NAD+, NADH, NADP+ and NADPH that were 
added to cell lysate immediately after the addition of ice-cold 1:1 mixture of PBS and 1 % 
DTAB in 0.2 M NaOH.
PPP and TCA cycle activity
PPP and TCA cycle activity were estimated based on PGD and OGDH activity, which were 
determined by measuring 14CO2 production from 1-14C-glucose and 1-14C-glutamine, 
respectively, based on a previously described method50. Fifteen thousand HeLa Tet3G 
Luciferase, LbNOX, mitoLbNOX, TPNOX or mitoTPNOX cells were seeded per well of a 
96-well plate in 0.2 ml of DMEM without pyruvate (US Biological, D9802) supplemented 
with 3.7 g/l NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044). Three replicate 
wells were used for each condition and wells with cells were separated from each other by at 
least one empty well to minimize bleed-through. Twenty-four hours later, media was 
exchanged to 0.2 ml of DMEM without pyruvate (US Biological, D9802) supplemented 
with 3.7 g/l NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044) and 300 ng/ml 
doxycycline. Twenty-four hours later, cells were washed twice with 0.2 ml of DMEM 
without pyruvate (US Biological, D9815-01) supplemented with 5 mM glucose, 4 mM (for 
PPP) or 1 mM (for TCA) glutamine, 5 mM sodium bicarbonate, 10 % dialyzed FBS, 25 mM 
HEPES (pH 7.4) and 300 ng/ml doxycycline and media was exchanged to 0.1 ml of the 
same medium supplemented with 5 μCi/ml 1-14C-glucose or 2 μCi/ml 1-14C-glutamine. 
Plates were covered with filter paper soaked in saturated Ba(OH)2, sealed with parafilm and 
incubated in 37°C incubator for three (PPP) or two (TCA cycle) hours. Filter paper was 
washed with acetone, dried at room temperature overnight, circles corresponding to 
individual wells were cut out, placed in 1.5 ml centrifuge tubes with open lids and heated at 
95°C for 15 min to dehydrate the filter paper. Amount of 14C bound to filter paper associated 
with each well was quantified using scintillation counter. No detectable 14CO2 production 
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was observed when 6-14C-glucose was used instead of 1-14C-glucose indicating that the 
majority of 14CO2 produced from 1-14C-glucose is derived from PPP.
Rescue of piericidin-induced inhibition of cell proliferation
Two thousand HeLa Tet3G Luciferase, LbNOX, mitoLbNOX, TPNOX and mitoTPNOX 
cells were seeded in 200 μl of DMEM without pyruvate (US Biological, D9802) 
supplemented with 3.7 g/l NaHCO3 and 10% dialyzed FBS (Life Technologies, 26400-044) 
per well in a black 96-well plate with a clear bottom (Corning, 3904). Twenty-four hours 
after seeding, 10 μl of 6 μg/ml doxycycline (300 ng/ml final concentration) or water was 
added to each well. Twenty-four hours after addition of doxycycline, medium was 
exchanged to DMEM without pyruvate (US Biological, D9802) supplemented with 3.7 g/l 
NaHCO3, 10% dialyzed FBS (Life Technologies, 26400-044), ± 1 μM piericidin and ± 300 
ng/ml doxycycline. After 0, 1, 2, 3 and 4 days after doxycycline addition, medium was 
aspirated and cells were fixed by adding 100 μl of 4% paraformaldehyde in PBS and 
incubating at room temperature for at least 30 min. Paraformaldehyde solution was aspirated 
and cells were stained with 200 μl of 1 μg/ml Hoechst 33345. Plates were covered with 
sealing aluminum foil and stored at 4 °C before counting cells in each well with Molecular 
Dynamics ImageXpress Ultra. Images of 96-well plates with fixed cells stained with 
Hoechst 33345 were collected using Molecular Devices ImageXpress Micro XLS. Four 
images were taken to cover the whole well. Images were analyzed and nuclei number per 
well was counted using CellProfiler 2.0 image analysis software51,52. The cell counting 
method had a linear range from 500 to 40000 cells per well as determined by counting plates 
with known number of cells seeded 6 hours prior to fixation.
Statistical analysis
Repeated measures ANOVA followed by Tukey’s multiple comparisons test was used to 
evaluate whether a significant difference exists between three or more groups of samples. 
ANOVA was justified as appropriate because the compared values are expected to be derived 
from a normal distribution and the variance is similar between the groups.
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Figure 1. Engineering TPNOX, a water-forming NADPH oxidase
(a) Sequence alignment of the NAD(P)H-binding region of the Rossmann fold domain 
(βαβ) of H2O-forming oxidase from L. brevis (LbNOX), E. coli glutathione reductase (GR) 
and engineered TPNOX. Dinucleotide-binding motif (DBM) and substrate specificity loop 
(SSL) are boxed. Residues Tyr157 and Tyr186, which undergo large movements upon 
coenzyme binding are highlighted in red. (b,c) X-ray structures of LbNOX–NADH (b, PDB 
code 5VN0) and GR–NADPH (c, PDB code 1GET) depicting the NAD(P)H-binding 
Rossmann fold domain. For clarity, alpha helix in both structures is shown as a cylinder. The 
measured distances are in Å.
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Figure 2. Catalytic activity of recombinant TPNOX
(a) The Michaelis–Menten analysis of the reaction catalyzed by TPNOX with NADPH or 
NADH. Inset shows kinetic parameters based on three independent experiments ± S.D. (b) 
Simultaneous measurements of oxygen and NADPH consumption by TPNOX. NADPH and 
enzyme were added as indicated by arrows.
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Figure 3. Structural determinants of NAD(P)H substrate selectivity in LbNOX and TPNOX
(a,b) The “two-tyrosine” switch in LbNOX. Comparison of the NADH binding site in 
coenzyme-free (a) and NADH-bound (b) LbNOX structures (PDB codes 5ER0 and 5VN0, 
respectively). Note the transition from blocking to open position of Tyr157 and Tyr186 side 
chains. (c,d) The role of GxGxxG/A dinucleotide-binding motif (DBM) in NADH (c) and 
NADPH (d) recognition in LbNOX and TPNOX (PDB codes 5VN0 and 5VOH, 
respectively). Note that Asp177 keeps the adenosine ribose ring of NADH in a tight contact 
with the GxGxxG motif (residues 154–159) due to the two strong hydrogen bonds with the 
2′ and 3′ hydroxyl groups. In TPNOX, the ribose ring is rotated slightly and shifted 
upwards. The side chain of Ala159 in TPNOX compensates for rotation of Gly154 peptide 
bond and restores communication with the redox site.
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Figure 4. Expression and activity of TPNOX in human cells
(a) Western blot of TPNOX, mitoTPNOX, LbNOX and mitoLbNOX expressed in HeLa 
cells 24-h after addition of doxycycline (Dox). (b) Subcellular localization of TPNOX, 
mitoTPNOX, LbNOX and mitoLbNOX determined by cell fractionation. Full gel images for 
a and b are in Supplementary Figure 5. (c) Effect of LbNOX, mitoLbNOX, TPNOX and 
mitoTPNOX expression on basal and antimycin-resistant (1 μM antimycin) oxygen 
consumption measured with Seahorse XF24 flux analyzer. Mean ± S.E.M. from n=3 
independent experiments with five biological replicates in each experiment. (d) Effect of 
LbNOX, mitoLbNOX, TPNOX and mitoTPNOX expression on total NADP+/NADPH ratio. 
Mean ± S.E.M. from n=6 independent experiments with two biological replicates in each 
experiment. P-values were determined using repeated measures one-way ANOVA followed 
by Tukey’s multiple comparisons test using GraphPad. ns, p > 0.05; ****, p < 0.0001.
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Figure 5. Metabolic consequences of compartment-specific perturbation of NADH or NADPH
Effects of overexpression of LbNOX, mitoLbNOX, TPNOX, or mitoTPNOX on: (a) 
Intracellular metabolite levels determined by GC-MS. Adapted from Supplementary Data 
Set 1. Mean ± S.E.M. from n = 6 biological replicates; (b,c) Flux through 6-
phophogluconate dehydrogenase (b) and 2-oxoglutarate dehydrogenase (c) as proxies for 
PPP and TCA cycle activities, respectively. Mean ± S.E.M. from n = 5 (b) and n = 4 (c) 
independent experiments with three biological replicates in each experiment; (d,e) Glucose 
consumption (d) and lactate production (e). Mean ± S.E.M. from n = 4 independent 
experiments with two biological replicates in each experiment; (f) Total [NAD+]/[NADH] 
levels. Mean ± S.E.M. from n = 6 independent experiments with two biological replicates in 
each experiment; (g) Cell proliferation defect caused by 1 μM piericidin treatment on day 1. 
Mean ± S.E.M. from n = 4 independent experiments with six biological replicates per 
timepoint in each experiment. (h) Mitochondrial enzyme systems that may mediate the 
exchange between mitochondrial NAD+/NADH and NADP+/NADPH reduction potentials. 
P-values were determined using repeated measures one-way ANOVA followed by Tukey’s 
multiple comparisons test using GraphPad. ns, p > 0.05; *, p < 0.05; **, p < 0.01; ****, p < 
0.0001.
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